Press release
Pharmacy OneSource Announces Free Webinar on Meaningful Use Requirements
How Pharmacy Can Prepare for Meaningful UseBellevue, Wash. – Wolters Kluwer Health announced today that Pharmacy OneSource, software-as-a-service provider of Sentri7, a clinical surveillance application, is hosting a complimentary webinar with John Poikonen, PharmD, on "Meaningful Use for the Pharmacist."
Not since "prospective payment" has two words caused so much activity in hospitals and health systems. Demonstrating "Meaningful Use" of health information technology can mean millions of stimulus dollars for a health system and even more once penalties kick in. Stage I of Meaningful Use preparation is well on the way with many hospitals. Stage II and III will up the ante, requiring even more input from pharmacy. Poikonen will outline the key elements of Meaningful Use, its opportunity for the medication use process and the way pharmacists can have an impact.
Meaningful Use for the Pharmacist
DATE: Wednesday, April 6, 2011
TIME: 12:00 PM - 1:00 PM EST
WHERE: http://www.pharmacyonesource.com/webinars
About the Presenter: John Poikonen, Pharm.D. is the Clinical Informatics Director at UMass Memorial Health Care, an Academic Medical Center and health system in central Massachusetts. His career has been split between software development and hospital pharmacy. He has been a director of pharmacy, software developer, patient safety pharmacist and informatics leader over the last 29 years in pharmacy. Most recently he was elected to the ASHP Executive Committee for Pharmacy Informatics and Technology Section in 2007 and was the recipient of the 2008 Leadership Award from the American Medical Informatics Association.
About Pharmacy OneSource
Pharmacy OneSource is healthcare's #1 Software-as-a-Service (SaaS) provider. Our more than 100 innovative team members provide best-in-class, SaaS solutions to current and future challenges within health-systems worldwide. Our SaaS solutions contribute to swift and safe healthcare through earlier, easier and better access to data. More than 1,300 healthcare organizations worldwide utilize our HIPAA compliant web-based services. Pharmacy OneSource is part of Wolters Kluwer Health (Philadelphia, PA), a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools, journals, and textbooks, such as Lippincott Williams & Wilkins; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span®, Facts & Comparisons® and ProVation® Medical.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company focused on professionals with annual revenues (2009) of £3.4 billion ($4.8 billion), approximately 19,300 employees worldwide and operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Visit our website, YouTube or follow @Wolters_Kluwer on Twitter for more information about our market positions, customers, brands, and organization.
Pharmacy OneSource
3535 Factoria Blvd. SE #440
Bellevue, WA 98006
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacy OneSource Announces Free Webinar on Meaningful Use Requirements here
News-ID: 169159 • Views: …
More Releases from Pharmacy OneSource, Inc.
Pharmacy OneSource Announces Free Webinar on USP 797 Compounding and Competency …
Best Practices and Resources for Training Compounding Personnel
Bellevue, Wash. – Wolters Kluwer Health announced today that Pharmacy OneSource, software-as-a-service provider of Simplifi 797, a quality assurance web application, is hosting a complimentary webinar with Eric S. Kastango, MBA, RPh, FASHP, in "Who Says You’re Competent to Compound CSPs? Evaluating Your Sterile Compounding Training and Competency Program."
USP Chapter 797 calls for compounding personnel to be adequately skilled, educated, instructed, and…
Saint Barnabas Health Care System Expands Sentri7 Use to Infection Prevention
Surveillance Software Expedites Workflow to Track and Report HAIs
Bellevue, Wash. – Wolters Kluwer Health announced today that Saint Barnabas Health Care System in New Jersey has added on the Infection Prevention Module of Sentri7 for the system’s surveillance and reporting needs.
Sentri7 web-based software can help streamline infection prevention workflows including isolation management, healthcare-associated infection (HAI) investigation and National Healthcare Safety Network (NHSN) reporting.
"We are customizing screens that will enhance our…
Pharmacy OneSource Announces Webinars on Bugs and Drugs
Examining Detection of Microorganisms and Implementation of Antimicrobial Stewardship Programs
Bellevue, Wash. – Wolters Kluwer Health announced today that Pharmacy OneSource, software-as-a-service provider of Sentri7, a real-time clinical surveillance, documentation and reporting system, is offering complimentary webinars in March with Eileen O'Rourke on microorganism detection and Amanda Hansen on antimicrobial stewardship.
Infection Preventionist Eileen O'Rourke will describe basic morphology of microorganisms. She will discuss the value of gram stain in directing treatment…
Pharmacy OneSource Announces Free Webinar with Patient Safety Expert
Barbara L. Olson will present on actionable ways to improve outcomes in the New Year
Bellevue, WA -- Pharmacy OneSource, software-as-a-service provider of the Sentri7 real-time clinical surveillance system, is pleased to announce a complimentary webinar presented by industry expert Barbara L. Olson, MS, RN, FISMP titled "From Intention to Outcome: Things You Can Do Tomorrow to Manage What's On Your Mind Today."
As a result of active listening, learners will be…
More Releases for Pharm
Fenbendazole Market Size, Share and Forecast By Key Players-Jin Dun Pharm, Shand …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Fenbendazole market is anticipated to grow at a compound annual growth rate (CAGR) of 16.05% between 2024 and 2031. The market is expected to grow to USD 68 Billion by 2024. The valuation is expected to reach USD 192.77 Billion by 2031.
The fenbendazole market is experiencing notable growth due to increasing awareness of parasitic infections in both…
Revolutionizing Revenue: Dexlansoprazole Sustained Release Capsule Market Trends …
Worldwide Market Reports announces the publication of its most recently generated research report titled, "Dexlansoprazole Sustained Release Capsule Market - Forecast to 2030", which offers a holistic view of the Dexlansoprazole Sustained Release Capsule market through systematic segmentation that covers every aspect of the target market. Dexlansoprazole Sustained Release Capsule with 100+ market data Tables, Pie Chat, Graphs, and Figures spread through Pages and easy-to-understand detailed analysis. The information is…
Paromomycin Sulfate Market 2030 by Top 10+ Players Pfizer,, Changrui Pharm,, ERF …
Paromomycin Sulfate is an antibiotic used to treat infections caused by certain parasites. It is commonly used to treat visceral leishmaniasis, a serious parasitic disease that affects the internal organs. The market for Paromomycin Sulfate is relatively small compared to other antibiotics, as it is primarily used to treat a specific type of parasitic infection. However, the market for Paromomycin Sulfate is expected to grow as the incidence of visceral…
Fosfomycin Market to Witness Huge Growth by 2026 | Northeast Pharm, Ercros, Shin …
The Latest Released Fosfomycin market study has evaluated the future growth potential of Global Fosfomycin market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities…
Clopidol Market updates, demand analysis, and expected growth forecast 2021-2027 …
Global “Clopidol” Market Size, Status, and Forecast 2021-2027. In-depth research accumulated to offer Latest insights about acute features of the global Clopidol market. This report provides a detailed overview of key factors in the Clopidol Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. The effect of the COVID-19 outbreak at the enterprise turned into completely assessed. Fully chance evaluation and enterprise recommendations…
Paromomycin Market updates, demand analysis, and expected growth forecast 2021-2 …
The new study on the Global “Paromomycin Market” 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the Paromomycin industry. Because of the in-depth overview of the Global Paromomycin market, the recent papers allow investors, traders, and manufacturers to plan some innovative techniques, and meanwhile, align them with operational and commercial enterprise models. Additionally, the Paromomycin market report offers crucial facets at the…